Emory University

  • The Georgia Clinical & Translational Science Alliance (Georgia CTSA) reached out to one of its own experts to employ a novel research approach to evaluate its team connections and dynamics. The aim of this research was to understand the complex web of relationships connecting managers at the top of organizations and how these relationships drive the top team’s performance and the organization’s
  • “The 1:1 mentoring, learning more about myself, and networking with other fellows has helped me feel less lost and alone. My experience in the Georgia CTSA TEAMS Program has been life-changing!” says Dr. Ines Gonzalez-Casanova. Now accepting applications for Mentors and Fellows for the 2021-2022 academic year cohort, the Georgia CTSA TEAMS (Translational Education and Mentoring in Science) Program
  • Illustration of people wearing face masks
    Emory University
    Hosted by the Georgia CTSA Community Engagement program, our 5th biennial forum celebrates translational research collaborations & partnerships. One Georgia: Advancing Health Equity Amidst a New Normal From Bench to Bedside to Curbside: Closing Health Equity Gaps Means All Hands on Deck Register Now! The Agenda includes: Challenges and Potential for Improving Health Equity with Digital Health – Dr
  • Three female researchers talking in front of a poster
    Emory University

    Hosted by the Georgia CTSA, the Southeast Regional Clinical & Translational Science Conference, held virtually on March 4 - 5, 2021, brings together researchers from across the region to present the best new clinical and translational research and build collaborative relationships. • Featured talks • Poster sessions showcasing clinical and translational science advances across the region •

  • illustration of black male doctor
    Emory University

    Emory School of Medicine and Morehouse School of Medicine invite you to join Black Men in White Coats: a film screening and discussion in honor of Black History Month. This documentary dissects the systemic barriers preventing black men from becoming medical doctors and the consequences on society at large. Watch the film anytime between now and February 23, then join a discussion on February 24

  • In a new study, the Evaluation and Continuous Improvement (ECI) team of the Georgia CTSA evaluated publications characterized as Big Splashes with immediate impact and publications with Ripple Effects over time, to understand how Georgia CTSA-supported research is ‘making waves’ that can accelerate translation. Previous systematic evaluations of the Georgia CTSA’s publication portfolio revealed a

  • Georgia CTSA Clinical Research Centers offer dedicated space, experienced staff, and resources to support research at a competitive cost. We assist investigators of all experience levels from Emory, Georgia Tech, Morehouse School of Medicine, UGA, and Children's Healthcare of Atlanta in serving adult and pediatric patient populations in Georgia. Watch this new video to learn more about how we help

  • “To have the greatest impact, you have to collaborate. You have to build a multi-disciplinary team that will sustain the research long after you’re gone,” says Dr. Ewan Cobran. Former Georgia CTSA UL1 Diversity Scholar, Ewan Cobran, PhD, Assistant Professor, College of Pharmacy, University of Georgia recently received an NIH K01 award for his research, “Genetic Literacy and Patient-Caregiver

  • Nephrotic Syndrome Rare Disease Clinical Research Network III (NEPTUNE)

    Focal and Segmental Glomerulosclerosis, Minimal Change Disease, and Membranous Nephropathy, presenting as Nephrotic Syndrome (NS), are a group of rare renal diseases that may cause serious complications and end-stage kidney disease, generating significant individual, societal and economic burdens. The Nephrotic Syndrome Study Network (NEPTUNE) brings together physician scientists at 26 sites in

  • Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN)

    Leukodystrophies are a complex, often progressive group of disorders affecting the white matter of the brain due to the loss or absence of myelin, the lipid membrane that insulates axons in the central nervous system. Despite advances in the diagnosis of these disorders, they remain widely under-recognized, with unmet gaps in clinical care and curative therapeutics. The Global Leukodystrophy

  • Dystonia Coalition (DC)

    Dystonia syndromes are disorders that cause certain regions of the body to have uncontrollable movements, including twisting, spasms, repetitive shaking, or jerking. The most common dystonia disorders affect the head and neck, eyelids, vocal cords, hands, forearms, and sometimes the entire body. The overall goal of the Dystonia Coalition is to accelerate progress in dystonia research. Specific

  • Congenital and Perinatal Infections Rare Diseases Clinical Research Consortium (CPIC)

    The Congenital and Perinatal Infections Consortium (CPIC) is focused on reducing the morbidity and mortality of rare viral infections such as congenital cytomegalovirus (CMV) disease, neonatal herpes simplex virus (HSV) infection, and neonatal viral sepsis caused by enteroviruses (EVs) and the related human parechoviruses (HPeVs). These infections have been grouped together because of their

  • For outreach and engagement efforts in ethnic and racial minority communities disproportionately affected by the pandemic, the National Institutes of Health has created the Community Engagement Alliance (CEAL) Against COVID-19 Disparities initiative. NIH selected teams in 11 states to focus on counties with underserved communities to facilitate the inclusion and participation in COVID-19 vaccine

  • "Today was a great day for science in the fight against COVID-19. We now have the potential for 2 COVID vaccines that are >90% effective. These results were better than we could have hoped. At Emory, we enrolled nearly 700 subjects across 3 sites, and many of our participants are from diverse racial and ethnic backgrounds. We are so proud of the hard work our teams put in to get these amazing

  • Emory University

    The Georgia CTSA Rapid Response Team expedited high-priority studies of experimental therapeutics and vaccines. Emory's first COVID-19 patient began receiving infusion therapy of Remdesivir within 48 hours as a result of Georgia CTSA's assistance in coordinating the approvals needed. Representatives from Emory research offices worked together in parallel to expedite 27 COVID-19 studies from March

  • Three female researchers talking in front of a poster
    Emory University

    Hosted by the Georgia CTSA, the Southeast Regional Clinical & Translational Science Conference, held virtually on March 4 - 5, 2021, brings together researchers from across the region to present the best new clinical and translational research and build collaborative relationships. Clinical and/or translational researchers working across the southeast are invited to submit an abstract by November

  • digital health information displayed on a smart phone
    Emory University

    Community members & community health experts, academic faculty & researchers across the CTSA are invited to attend this special webinar via Zoom: "Bridging Digital Research and Community/Patient Engagement Strategies to Advance a Healthy Georgia" Overarching Purpose: To leverage academic-community partnered strategies that will contribute to the nationally recognized impetus to link geographically

  • Emory University
    Georgia Institute of Technology
    The Georgia CTSA—a partnership between Emory University, Georgia Tech, Morehouse School of Medicine, and the University of Georgia—is offering a free, online educational resource that introduces foundational Clinical and Translational Research (CTR) concepts through written material, videos, interactive graphics, and self-assessments. This exploration is organized into 4 parts that will each take
  • “Especially during the COVID-19 pandemic, our Diabetes Prevention program has become a lifeline for many Georgians. Participants look forward to this session as a way they can connect with others at a time when they’re missing out on that social connection. It’s helping them take stock in their nutrition and health behaviors. Our program has become a source of hope and encouragement for many. They

  • The National Institutes of Health (NIH)’s Rapid Acceleration of Diagnostics (RADx) initiative has awarded contracts to seven biomedical diagnostic companies whose innovative technologies will increase the availability of COVID-19 tests by millions per week as early as September 2020. While expanding the nation’s testing capacity, these testing technologies use different methods including more

  • Georgia CTSA and Emory University including the Emory Medical Laboratory assisted the Centers for Disease Control and Prevention (CDC) and the Federal Emergency Management Agency (FEMA) in conducting a serosurvey to assess the presence of antibodies to SARS-CoV-2 among their workforce who are participating in the COVID-19 response. Georgia CTSA completed more than 1,200 blood draws for a COVID-19

  • Georgia CTSA investigators Evan Anderson, MD, and Nadine Rouphael, MD, co-authored results published in NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2022483 reporting a robust anti–SARS-CoV-2 immune response in all study participants during the investigational mRNA-1273 vaccine phase 1 trial. Anderson is the principal investigator and Rouphael is the contact principal investigator for the

  • Congratulations to Jessica Shantha, MD, Assistant Professor, Section of Vitreoretinal Surgery and Diseases and Section of Uveitis and Vasculitis, Emory Eye Center, and Georgia Clinical & Translational Science Alliance (Georgia CTSA) Master in Science in Clinical Research (MSCR) trainee who is the recipient of the American Academy of Ophthalmology’s 2020 Artemis Award. This award recognizes a young

  • The Georgia CTSA Evaluation and Continuous Improvement (ECI) program recently completed a study providing greater insight into the range and depth of short-term influence and long-term impact made by a portfolio of 250 Georgia CTSA-supported pediatric publications. This evaluation of Georgia CTSA’s pediatric research output found a body of work that is highly impactful compared to similar work by

  • SIREN Logo

    The Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) is a clinical trials network funded by the National Institute for Neurological Disorders and Stroke (NINDS), the National Heart Lung and Blood Institute (NHLBI) and the National Center for Advancing Translational Science (NCATS). The goal of the SIREN Network is to improve the outcomes of patients with neurologic, cardiac

  • “Classes relatively seamlessly have transitioned to an online platform.” “Online classes are equally good. Instructors have adapted.” “Clear communication about changes.” “Everyone has been very flexible.” These are comments from Georgia CTSA students who transitioned to online learning. Halfway through the Spring 2020 semester, the Georgia Clinical & Translational Science Alliance (Georgia CTSA)

  • Georgia Clinical & Translational Science Alliance
    Emory University

    Hear from the experts and share your experiences! Join Marissa Shuffler, Ph.D., (Clemson University) and Christopher Wiese, Ph.D., (Georgia Tech) to learn how to manage your virtual teams. They will offer evidence-based guidelines and practical advice. Turn your team of experts into expert virtual teams! https://bit.ly/ManagingVTeams Instructions to use Zoom: Download the Zoom app from Google Play

  • Two of Georgia CTSA’s leaders head up the NIBIB-funded Atlanta Center Microsystems Engineered Point of Care Technologies (ACME POCT) which has been selected by the NIH, along with their institutions - Emory, Georgia Tech, and Children’s Healthcare of Atlanta - to test and validate some of the most promising technologies for COVID-19 diagnostic testing. Wilbur Lam, MD, PhD is the Principal

  • “The Georgia CTSA is an incredible group of colleagues to build together. My experience in the Georgia CTSA KL2 Program is just one example of how an investigator is being supported by this talented team of people and comprehensive resources to make exciting advances and produce outstanding work,” says Dr. Joshua Levy. Joshua M. Levy, MD, MPH, Emory Sinus, Nasal & Allergy Center; Assistant

  • “What we have learned about inflammation for HIV is a foundation for streamlined effective approaches towards other diseases and viral infections including COVID,” says Dr. Christina Gavegnano. Christina Gavegnano, PhD, Assistant Professor, Emory University School of Medicine, and Georgia Clinical & Translational Science Alliance (Georgia CTSA) Certificate Program in Translational Research (CPTR)